EXVITECH

Welcome to the Brand page for “EXVITECH”, which is offered here for Pharmaceutical and nutraceutical preparations for the treatment of rare haematologic, oncologic, respiratory, immune, cardio-vascular, metabolic, genitourinary, neurologic, central nervous system, depressive, dermatologic, inflammatory and muscle-skeleton diseases, and aging and tissue and organ transplantation diseases (ers); pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the muscle-skeletal system, the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, haematology, in tissue and organ transplantation, in ophthalmology and for the treatment of gastroenterological disorders;medical and scientific research services in the field of new medical treatments, cancer, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the muscle-skeletal system, the genitourinary system; medical and scientific research services for the treatment of inflammatory disorders; medical and scientific research services for use in dermatology, oncology, haematology, and for gastroenterological disorders; medical and scientific research in the field of medical products; scientific research and development of new pharmaceutical products; medical laboratories for developing personalized treatments;.

Its status is currently believed to be active. Its class is unavailable. “EXVITECH” is believed to be currently owned by “Orphamed, S.L.”